Jia-Xi Duan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jia-Xi Duan has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
Chen-Yu Zhang
Department of Physiology, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China
9 shared publicationsWen-Jing Zhong
Department of Geriatric Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China
8 shared publicationsYu-Biao Liu
Department of Physiology, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China
8 shared publications- Yong Zhou
Department of Physiology, School of Basic Medicine Science, Central South University, Changsha, China
6 shared publications - Cha-Xiang Guan
Central South University
5 shared publications Nan-Shi-Yu Yang
Department of Physiology, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China
5 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Wiley in Advanced Science
- p. e78307
PDHA1 Hyperactivation‐Mediated Glucose Metabolism Reprogramming Fuels Neutrophil NETosis and Promotes Acute Lung Injury
Neutrophil extracellular trap (NET) formation, termed NETosis, is a key driver of lung tissue injury in acute lung injury/acute respiratory distress syndrome (ALI/ARDS). However, the precise mechanisms that trigger neutrophil NETosis remain incompletely understood. Here, we observed that neutrophils from both ALI mice and ARDS patients exhibited NETosis alongside a pronounced selective metabolic shift, characterized by enhanced oxidative phosphorylation (OXPHOS) and attenuated glycolytic activity. Phosphoproteomic profiling revealed that this shift was driven by aberrant activation of pyruvate dehydrogenase E1 subunit alpha (PDHA1), resulting from its dephosphorylation at Ser293. Inhibiting PDHA1 activity, using either the inhibitor 3‐fluoropyruvate (3‐FP) or genetic knockdown, effectively reversed this selective metabolic reprogramming and suppressed NETosis. We further constructed neutrophil‐targeted 3‐FP‐loaded albumin nanoparticles (3‐FP‐BSA NPs). These nanoparticles were specifically taken up by activated neutrophils, markedly inhibited NETosis, and alleviated lipopolysaccharide‐induced ALI in mice. Mechanistically, RNA‐seq revealed the enrichment of the AMPK in neutrophils during NETosis. AMPK phosphorylated PDHA1 at Ser314, which disrupted the PDHA1‐pyruvate dehydrogenase kinase 1 (PDK1) interaction and inhibited PDHA1 phosphorylation at Ser293. Ultimately, PDHA1 hyperactivation‐driven selective metabolic reprogramming precipitated mitochondrial stress and mtROS accumulation, thereby initiating NETosis. This study defines a targetable metabolic pathway in neutrophils and advances a specific PDHA1‐nanotherapeutic strategy against ALI/ARDS.
- 14 October 2026
- Published by Wiley in Advanced Science
- p. e78307
Open AccessPDHA1 Hyperactivation‐Mediated Glucose Metabolism Reprogramming Fuels Neutrophil NETosis and Promotes Acute Lung Injury
Neutrophil extracellular trap (NET) formation, termed NETosis, is a key driver of lung tissue injury in acute lung injury/acute respiratory distress syndrome (ALI/ARDS). However, the precise mechanisms that trigger neutrophil NETosis remain incompletely understood. Here, we observed that neutrophils from both ALI mice and ARDS patients exhibited NETosis alongside a pronounced selective metabolic shift, characterized by enhanced oxidative phosphorylation (OXPHOS) and attenuated glycolytic activity. Phosphoproteomic profiling revealed that this shift was driven by aberrant activation of pyruvate dehydrogenase E1 subunit alpha (PDHA1), resulting from its dephosphorylation at Ser293. Inhibiting PDHA1 activity, using either the inhibitor 3‐fluoropyruvate (3‐FP) or genetic knockdown, effectively reversed this selective metabolic reprogramming and suppressed NETosis. We further constructed neutrophil‐targeted 3‐FP‐loaded albumin nanoparticles (3‐FP‐BSA NPs). These nanoparticles were specifically taken up by activated neutrophils, markedly inhibited NETosis, and alleviated lipopolysaccharide‐induced ALI in mice. Mechanistically, RNA‐seq revealed the enrichment of the AMPK in neutrophils during NETosis. AMPK phosphorylated PDHA1 at Ser314, which disrupted the PDHA1‐pyruvate dehydrogenase kinase 1 (PDK1) interaction and inhibited PDHA1 phosphorylation at Ser293. Ultimately, PDHA1 hyperactivation‐driven selective metabolic reprogramming precipitated mitochondrial stress and mtROS accumulation, thereby initiating NETosis. This study defines a targetable metabolic pathway in neutrophils and advances a specific PDHA1‐nanotherapeutic strategy against ALI/ARDS.
- Open Access
- 25 June 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
NINJ1 plays a vital role in the release of neutrophil extracellular traps during acute lung injury
Excessive neutrophil extracellular traps (NETs) formation is a significant contributor to acute lung injury (ALI), making its inhibition a novel therapeutic avenue to improve outcomes. In this study, we revealed that a novel pore-forming protein ninjurin-1 (NINJ1) was highly expressed in pro-inflammatory neutrophil subpopulations during ALI, using public single-cell RNA sequencing and hotspot analysis. Furthermore, we demonstrated that the NINJ1 oligomerization was essential for the NET release in neutrophils from both acute respiratory distress syndrome (ARDS) patients and ALI mice. Genetic ablation of Ninj1 in neutrophils abolished NET release, thereby attenuating pulmonary dysfunction and reducing ALI-related lethality. Mechanistically, we found that K45 and N60 are critical for NINJ1 oligomerization and subsequent NET release. In summary, our findings reveal a novel pore-forming protein-mediated mechanism for NET release and highlight NINJ1 as a potential therapeutic target for the treatment of ALI/ARDS.
- 25 June 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Open AccessNINJ1 plays a vital role in the release of neutrophil extracellular traps during acute lung injury
Excessive neutrophil extracellular traps (NETs) formation is a significant contributor to acute lung injury (ALI), making its inhibition a novel therapeutic avenue to improve outcomes. In this study, we revealed that a novel pore-forming protein ninjurin-1 (NINJ1) was highly expressed in pro-inflammatory neutrophil subpopulations during ALI, using public single-cell RNA sequencing and hotspot analysis. Furthermore, we demonstrated that the NINJ1 oligomerization was essential for the NET release in neutrophils from both acute respiratory distress syndrome (ARDS) patients and ALI mice. Genetic ablation of Ninj1 in neutrophils abolished NET release, thereby attenuating pulmonary dysfunction and reducing ALI-related lethality. Mechanistically, we found that K45 and N60 are critical for NINJ1 oligomerization and subsequent NET release. In summary, our findings reveal a novel pore-forming protein-mediated mechanism for NET release and highlight NINJ1 as a potential therapeutic target for the treatment of ALI/ARDS.
- Open Access
- 6 March 2026
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 83 (1)
Fibroblast growth factor-inducible 14 accelerates pulmonary fibrosis by inducing fibroblast senescence in mice
Pulmonary fibrosis (PF) is a chronic and fatal aging-related pulmonary disease. Emerging evidence suggests that fibroblast senescence plays a pivotal role in the initiation and progression of PF. Senescent fibroblasts accumulate in fibrotic lungs, driving excessive extracellular matrix (ECM) deposition, which disrupts tissue architecture and compromises pulmonary function. Notably, senolytic therapy targeting these senescent fibroblasts has shown significant efficacy in ameliorating PF. Therefore, elucidating the mechanisms underlying fibroblast senescence is a promising approach to prevent PF. Herein, our results identify fibroblast growth factor-inducible 14 (Fn14) as a critical mediator in the senescence of fibroblasts. We found that Fn14 was up-regulated in pulmonary fibroblasts from both PF patients and bleomycin (BLM)-treated mice. While knockdown of Fn14 attenuated pulmonary structural disruption and reduced fibroblast senescence in the lung of BLM-treated mice. In vitro, Fn14 activation promoted cellular senescence in pulmonary fibroblasts. Mechanistically, Fn14-induced mitophagy impairment resulted in mitochondrial DNA (mtDNA) leakage, which subsequently activated the cGAS-STING signaling. Moreover, restoring mitophagy or inhibiting cGAS ameliorated fibroblast senescence induced by Fn14 activation. Collectively, these results provide comprehensive insight into the pro-fibrotic role of Fn14 in the development of PF by inducing fibroblast senescence and shed light on the Fn14-targeting therapeutics for PF.
- 6 March 2026
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 83 (1)
Open AccessFibroblast growth factor-inducible 14 accelerates pulmonary fibrosis by inducing fibroblast senescence in mice
Pulmonary fibrosis (PF) is a chronic and fatal aging-related pulmonary disease. Emerging evidence suggests that fibroblast senescence plays a pivotal role in the initiation and progression of PF. Senescent fibroblasts accumulate in fibrotic lungs, driving excessive extracellular matrix (ECM) deposition, which disrupts tissue architecture and compromises pulmonary function. Notably, senolytic therapy targeting these senescent fibroblasts has shown significant efficacy in ameliorating PF. Therefore, elucidating the mechanisms underlying fibroblast senescence is a promising approach to prevent PF. Herein, our results identify fibroblast growth factor-inducible 14 (Fn14) as a critical mediator in the senescence of fibroblasts. We found that Fn14 was up-regulated in pulmonary fibroblasts from both PF patients and bleomycin (BLM)-treated mice. While knockdown of Fn14 attenuated pulmonary structural disruption and reduced fibroblast senescence in the lung of BLM-treated mice. In vitro, Fn14 activation promoted cellular senescence in pulmonary fibroblasts. Mechanistically, Fn14-induced mitophagy impairment resulted in mitochondrial DNA (mtDNA) leakage, which subsequently activated the cGAS-STING signaling. Moreover, restoring mitophagy or inhibiting cGAS ameliorated fibroblast senescence induced by Fn14 activation. Collectively, these results provide comprehensive insight into the pro-fibrotic role of Fn14 in the development of PF by inducing fibroblast senescence and shed light on the Fn14-targeting therapeutics for PF.
- Open Access
- 13 January 2026
- Published by Springer Nature in Research Square
NINJ1 plays a vital role in the release of neutrophil extracellular traps in acute lung injury
Excessive neutrophil extracellular traps (NETs) formation is a significant contributor to acute lung injury (ALI), making its inhibition a novel therapeutic avenue to improve outcomes. In this study, we revealed that a novel pore-forming protein ninjurin-1 (NINJ1) was predominantly highly expressed in pro-inflammatory neutrophil subpopulations during ALI, using public single-cell RNA sequencing and hotspot analysis. Furthermore, we demonstrated that the NINJ1 oligomerization was essential for the NETs release of neutrophils from both acute respiratory distress syndrome (ARDS) patients and ALI mice. Genetic ablation of Ninj1 in neutrophils abolished NETs release, thereby attenuating pulmonary dysfunction and reducing ALI-related lethality. Mechanistically, we found that N-glycosylation of NINJ1 at the 60 site was the major contributor to its oligomerization and NETs release. In summary, our findings reveal a novel pore-forming protein-mediated mechanism for NETs release and highlight NINJ1 as a potential therapeutic target for the treatment of ALI/ARDS.
- 13 January 2026
- Published by Springer Nature in Research Square
Open AccessNINJ1 plays a vital role in the release of neutrophil extracellular traps in acute lung injury
Excessive neutrophil extracellular traps (NETs) formation is a significant contributor to acute lung injury (ALI), making its inhibition a novel therapeutic avenue to improve outcomes. In this study, we revealed that a novel pore-forming protein ninjurin-1 (NINJ1) was predominantly highly expressed in pro-inflammatory neutrophil subpopulations during ALI, using public single-cell RNA sequencing and hotspot analysis. Furthermore, we demonstrated that the NINJ1 oligomerization was essential for the NETs release of neutrophils from both acute respiratory distress syndrome (ARDS) patients and ALI mice. Genetic ablation of Ninj1 in neutrophils abolished NETs release, thereby attenuating pulmonary dysfunction and reducing ALI-related lethality. Mechanistically, we found that N-glycosylation of NINJ1 at the 60 site was the major contributor to its oligomerization and NETs release. In summary, our findings reveal a novel pore-forming protein-mediated mechanism for NETs release and highlight NINJ1 as a potential therapeutic target for the treatment of ALI/ARDS.
- 7 January 2026
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 104 (1) , 25
Spil-mediated sEH overexpression contributes to the senescence of alveolar epithelial cells during pulmonary fibrosis in mice
Alveolar epithelial cell (AEC) senescence is a crucial driver of pulmonary fibrosis (PF). Epoxyeicosatrienoic acids (EETs) are synthesized from arachidonic
- 7 January 2026
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 104 (1) , 25
Spil-mediated sEH overexpression contributes to the senescence of alveolar epithelial cells during pulmonary fibrosis in mice
Alveolar epithelial cell (AEC) senescence is a crucial driver of pulmonary fibrosis (PF). Epoxyeicosatrienoic acids (EETs) are synthesized from arachidonic
- Open Access
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 9
PDHA1 Hyperactivation Orchestrates Metabolic Reprogramming Promoting Endothelial Senescence
While recent studies have established links between metabolic reprogramming and inflammatory senescence, the specific metabolic drivers in vascular aging remain incompletely defined. Here, we systematically characterized senescent phenotypes and targeted metabolomic profiles in primary aging endothelial cells, identifying a pyruvate dehydrogenase E1 component subunit alpha (PDHA1)-dependent metabolic shift as a hallmark of cellular senescence. Using a D-galactose-induced senescence model, we demonstrated that endothelial-specific Pdha1 knockdown alleviated pulmonary vascular endothelial senescence and associated functional decline. Further investigation revealed that PDHA1 hyperactivation disrupts mitochondrial homeostasis, leading to excessive mitochondrial reactive oxygen species production, oxidative mitochondrial DNA damage, and subsequent cytosolic mitochondrial DNA release, thereby triggering cyclic GMP-AMP synthase-mediated senescence. Mechanistically, decreased lactylation of PDHA1 at lysine 336 potentiated its activity and promoted dephosphorylation at serine 293. This posttranslational cross talk enhanced PDHA1 activation and drove a prosenescent metabolic shift. Together, our results elucidate that a previously unrecognized PDHA1 hyperactivation promotes endothelial senescence.
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 9
Open AccessPDHA1 Hyperactivation Orchestrates Metabolic Reprogramming Promoting Endothelial Senescence
While recent studies have established links between metabolic reprogramming and inflammatory senescence, the specific metabolic drivers in vascular aging remain incompletely defined. Here, we systematically characterized senescent phenotypes and targeted metabolomic profiles in primary aging endothelial cells, identifying a pyruvate dehydrogenase E1 component subunit alpha (PDHA1)-dependent metabolic shift as a hallmark of cellular senescence. Using a D-galactose-induced senescence model, we demonstrated that endothelial-specific Pdha1 knockdown alleviated pulmonary vascular endothelial senescence and associated functional decline. Further investigation revealed that PDHA1 hyperactivation disrupts mitochondrial homeostasis, leading to excessive mitochondrial reactive oxygen species production, oxidative mitochondrial DNA damage, and subsequent cytosolic mitochondrial DNA release, thereby triggering cyclic GMP-AMP synthase-mediated senescence. Mechanistically, decreased lactylation of PDHA1 at lysine 336 potentiated its activity and promoted dephosphorylation at serine 293. This posttranslational cross talk enhanced PDHA1 activation and drove a prosenescent metabolic shift. Together, our results elucidate that a previously unrecognized PDHA1 hyperactivation promotes endothelial senescence.
- Open Access
- 3 September 2025
- Published by Springer Nature in Research Square
Fibroblast growth factor-inducible 14 accelerates pulmonary fibrosis by inducing fibroblast senescence in mice
Pulmonary fibrosis (PF) is a chronic and fatal aging-related pulmonary disease. Emerging evidence suggest that fibroblast senescence plays a pivotal role in the initiation and progression of PF. Senescent fibroblasts accumulate in fibrotic lungs, driving excessive extracellular matrix (ECM) deposition, which disrupts tissue architecture and compromises pulmonary function. Notably, senolytic therapy targeting these senescent fibroblasts has shown significant efficacy in ameliorating PF. Therefore, elucidating the mechanisms underlying fibroblast senescence is a promising approach to prevent PF. Herein, our results identify fibroblast growth factor-inducible 14 (Fn14) as a critical mediator in the senescence of fibroblasts. We found that Fn14 was up-regulated in pulmonary fibroblasts from both PF patients and bleomycin (BLM)-treated mice. While knockdown of Fn14 attenuated pulmonary structural disruption and reduced fibroblast senescence in the lung of BLM-treated mice. In vitro , Fn14 activation promoted cellular senescence in pulmonary fibroblasts. Mechanistically, Fn14-induced mitophagy impairment resulted in mitochondrial DNA (mtDNA) leakage, which subsequently activated the cGAS-STING signaling. Moreover, restoring mitophagy or inhibiting cGAS ameliorated fibroblast senescence induced by Fn14 activation. Collectively, these results provide comprehensive insight into the pro-fibrotic role of Fn14 in the development of PF by inducing fibroblast senescence and shed light on the Fn14-targeting therapeutics for PF.
- 3 September 2025
- Published by Springer Nature in Research Square
Open AccessFibroblast growth factor-inducible 14 accelerates pulmonary fibrosis by inducing fibroblast senescence in mice
Pulmonary fibrosis (PF) is a chronic and fatal aging-related pulmonary disease. Emerging evidence suggest that fibroblast senescence plays a pivotal role in the initiation and progression of PF. Senescent fibroblasts accumulate in fibrotic lungs, driving excessive extracellular matrix (ECM) deposition, which disrupts tissue architecture and compromises pulmonary function. Notably, senolytic therapy targeting these senescent fibroblasts has shown significant efficacy in ameliorating PF. Therefore, elucidating the mechanisms underlying fibroblast senescence is a promising approach to prevent PF. Herein, our results identify fibroblast growth factor-inducible 14 (Fn14) as a critical mediator in the senescence of fibroblasts. We found that Fn14 was up-regulated in pulmonary fibroblasts from both PF patients and bleomycin (BLM)-treated mice. While knockdown of Fn14 attenuated pulmonary structural disruption and reduced fibroblast senescence in the lung of BLM-treated mice. In vitro , Fn14 activation promoted cellular senescence in pulmonary fibroblasts. Mechanistically, Fn14-induced mitophagy impairment resulted in mitochondrial DNA (mtDNA) leakage, which subsequently activated the cGAS-STING signaling. Moreover, restoring mitophagy or inhibiting cGAS ameliorated fibroblast senescence induced by Fn14 activation. Collectively, these results provide comprehensive insight into the pro-fibrotic role of Fn14 in the development of PF by inducing fibroblast senescence and shed light on the Fn14-targeting therapeutics for PF.
- Open Access
- 26 November 2024
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 22 (1) , 1-19
Cadmium exposure triggers alveolar epithelial cell pyroptosis by inducing mitochondrial oxidative stress and activating the cGAS-STING pathway
Cadmium is a ubiquitous toxic metal and environmental pollutant. More and more studies have shown that cadmium exposure can damage lung function. Alveolar epithelial cells (AECs) are structural cells that maintain the stability of lung function. The injury of AECs is an essential determinant of many lung diseases. In the lung, cadmium accumulation can cause damage to AECs. However, the specific mechanism is still unclear. This study aimed to explore the key mechanism underlying the injury of AECs caused by cadmium exposure. The main modes of death of AECs induced by cadmium exposure were evaluated in vivo and in vitro. Transcriptomic changes of AECs induced by cadmium exposure were analyzed using RNA-sequence. Mitochondrial ROS scavengers (mitoQ), voltage-dependent anion channel 1 (VDAC1) oligomer inhibitor (VBIT4), and cyclic GMP-AMP synthase (cGAS) inhibitor (RU.521) were used to assess whether cadmium exposure triggered pyroptosis of AECs by inducing mitochondrial stress to activate the cGAS-STING-NLRP3 axis. In this study, the expression of pyroptosis-related proteins was significantly up-regulated in the cadmium-exposed AECs, while the expression of apoptosis, necroptosis, and ferroptosis-related proteins had no significant up-regulated. The pan-caspase inhibitor ZVAD-FMK significantly reduced cell death. Thus, our research indicates that pyroptosis is the primary type of AEC death exported to cadmium. Mechanistically, RNA-seq and Western Blot results showed that cadmium exposure activated the cGAS-STING pathway in AECs and promoted pyroptosis by activating the NLRP3 inflammasome. Further investigation of the mechanism found that cadmium exposure caused mitochondrial oxidative stress, which led to mtDNA leakage into the cytoplasm and activated the cGAS-STING pathway. In addition, inhibition of the cGAS-STING pathway significantly alleviated lung injury induced by cadmium exposure in mice. Our study confirmed that pyroptosis of AECs was a vital mechanism of lung injury after cadmium exposure in a cGAS-STING-dependent manner, which may provide a new target for the treatment of lung diseases induced by cadmium exposure.
- 26 November 2024
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 22 (1) , 1-19
Open AccessCadmium exposure triggers alveolar epithelial cell pyroptosis by inducing mitochondrial oxidative stress and activating the cGAS-STING pathway
Cadmium is a ubiquitous toxic metal and environmental pollutant. More and more studies have shown that cadmium exposure can damage lung function. Alveolar epithelial cells (AECs) are structural cells that maintain the stability of lung function. The injury of AECs is an essential determinant of many lung diseases. In the lung, cadmium accumulation can cause damage to AECs. However, the specific mechanism is still unclear. This study aimed to explore the key mechanism underlying the injury of AECs caused by cadmium exposure. The main modes of death of AECs induced by cadmium exposure were evaluated in vivo and in vitro. Transcriptomic changes of AECs induced by cadmium exposure were analyzed using RNA-sequence. Mitochondrial ROS scavengers (mitoQ), voltage-dependent anion channel 1 (VDAC1) oligomer inhibitor (VBIT4), and cyclic GMP-AMP synthase (cGAS) inhibitor (RU.521) were used to assess whether cadmium exposure triggered pyroptosis of AECs by inducing mitochondrial stress to activate the cGAS-STING-NLRP3 axis. In this study, the expression of pyroptosis-related proteins was significantly up-regulated in the cadmium-exposed AECs, while the expression of apoptosis, necroptosis, and ferroptosis-related proteins had no significant up-regulated. The pan-caspase inhibitor ZVAD-FMK significantly reduced cell death. Thus, our research indicates that pyroptosis is the primary type of AEC death exported to cadmium. Mechanistically, RNA-seq and Western Blot results showed that cadmium exposure activated the cGAS-STING pathway in AECs and promoted pyroptosis by activating the NLRP3 inflammasome. Further investigation of the mechanism found that cadmium exposure caused mitochondrial oxidative stress, which led to mtDNA leakage into the cytoplasm and activated the cGAS-STING pathway. In addition, inhibition of the cGAS-STING pathway significantly alleviated lung injury induced by cadmium exposure in mice. Our study confirmed that pyroptosis of AECs was a vital mechanism of lung injury after cadmium exposure in a cGAS-STING-dependent manner, which may provide a new target for the treatment of lung diseases induced by cadmium exposure.
- Open Access
- 25 November 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 169, 115937
Epoxyeicosatrienoic acids alleviate alveolar epithelial cell senescence by inhibiting mitophagy through NOX4/Nrf2 pathway
- 25 November 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 169, 115937
Open AccessEpoxyeicosatrienoic acids alleviate alveolar epithelial cell senescence by inhibiting mitophagy through NOX4/Nrf2 pathway